Keros Therapeutics Inc
KROS (Keros Therapeutics Inc) may reap gains as insiders became active recently
Anna Perez
Keros Therapeutics Inc’s filing revealed that its 10% Owner Pontifax Management 4 G.P. (20 unloaded Company’s shares for reported $84.98 ...
10% Owner Pontifax Management 4 G.P. (20 sale 4,787,331 shares of Keros Therapeutics Inc [KROS]
Jaxson Clark
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its ...
Wells Fargo initates Keros Therapeutics Inc (KROS) rating to an Overweight
Samantha Gray
In a filing, Keros Therapeutics Inc revealed its 10% Owner Pontifax Management 4 G.P. (20 unloaded Company’s shares for reported ...
Wells Fargo initates Keros Therapeutics Inc (KROS) stock to an Overweight
Samantha Gray
Keros Therapeutics Inc’s recent filing unveils that its 10% Owner Pontifax Management 4 G.P. (20 unloaded Company’s shares for reported ...
Wells Fargo initates Keros Therapeutics Inc (KROS) rating to an Overweight
Samantha Gray
In a filing, Keros Therapeutics Inc revealed its 10% Owner Pontifax Management 4 G.P. (20 unloaded Company’s shares for reported ...
